Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Prev Med. 2020 Jul 18;139:106215. doi: 10.1016/j.ypmed.2020.106215

Home Smoking and Vaping Policies among US Adults: Results from the Population Assessment of Tobacco and Health (PATH) Study, Wave 3

Dongmei Li 1, Hangchuan Shi 1, Zidian Xie 1, Irfan Rahman 2, Scott McIntosh 3, Maansi Bansal-Travers 4, Jonathan P Winickoff 5,6,7, Jeremy E Drehmer 5,6, Deborah J Ossip 3
PMCID: PMC7494576  NIHMSID: NIHMS1613303  PMID: 32693178

Abstract

We examined the prevalence of home smoking and vaping restrictions among US adults, and compared home policy differences for smoking and vaping among vapers, smokers, and dual users.

Secondary data from the Population Assessment of Tobacco and Health (PATH) Study Wave 3 (2015 – 2016) with 28,148 adults were analyzed using weighted multivariable logistic regression models that account for complex sampling design to compare differences in home policies among non-users, vapers only, smokers only, and dual users.

Compared to never-users, current vapers who were ex-smokers and dual users were more likely to allow home vaping (aOR = 11.06, 95% CI: 8.04 – 15.21; aOR = 6.44, 95% CI: 5.01 – 8.28) and smoking (aOR = 1.62, 95% CI: 1.19 – 2.22; aOR = 3.58, 95% CI: 2.88 – 4.45). Current smokers were more likely to allow vaping (aOR = 3.53, 95% CI: 3.06 – 4.06) and smoking (aOR = 4.27, 95% CI: 3.73 – 4.89) inside the home than never-users. Current vapers who never smoked were more likely to allow vaping inside the home than never-users (aOR = 2.45, 95% CI: 1.53 – 3.93). Vapers reported much lower rates of vape-free home policies relative to both their smoke-free home policies and to vape-free home policies among smokers.

Vapers may be using e-cigarettes in hopes of harm reduction, but interpreting “harm reduction” as safe, thus exposing non-users in their homes to second- and thirdhand aerosols. This underscores the need to healthcare providers to extend intervention with vapers to include implementing vape-free home policies.

Introduction

The health effects from cigarette smoking and associated risks from secondhand smoke exposure are well studied 13. Although long-term effects of exposure to secondhand aerosol (SHA) on health are still unknown, the toxicants in e-cigarette aerosol include nicotine, carbonyls, ultrafine particulates, heavy metals and volatile organic compounds 4, which are substances known to be biologically associated with cardiovascular disease 5 and carcinogenesis 6 in other contexts. Hess et al. systematically reviewed 16 studies before 2015 on health risks from e-cigarette SHA and concluded that although they are at lower risk compared to conventional tobacco smoke, bystanders who are passively exposed to SHA are at risk of inhaling numerous pollutants that are known to be associated with developing respiratory diseases in different contexts 7. A recent study also found an association between SHA exposure and increased risk of asthma exacerbations in children 8. Previous studies have found that e-cigarette aerosol includes high concentration of ultrafine particles (even higher than cigarette smoking), which can worsen respiratory disease symptoms like asthma and might trigger heart attack 912. One of the primary components in the e-cigarettes aerosol is propylene glycol, which is a chemical that can generate known carcinogens when heated, and can cause eye, throat, and airway irritation with short-term exposure 13,14. Previous experimental studies on human lung cells also found the exposure to e-cigarette aerosols could damage lung tissues with increased oxidative stress and inflammatory response 15. In addition, nicotine and other chemicals deposited on indoor surface from e-cigarette aerosols increases the risk of third-hand exposure 1618.

The public perceptions of harms associated with secondhand exposure to e-cigarette aerosol are low 19. A recent study found only 1 in 5 adults would ask others not to vape in public places compared with 1 in 2 adults who would ask others not to smoke in public places (restaurants, bars, and parks) 20. Data from an online survey in 2015 showed that almost 40% of US adults failed to identify potential harms of SHA on children (i.e., either responded “no harm” or “don’t know”) 21. Similarly, a recent national survey of public knowledge regarding composition of e-cigarette SHA on US adults found that 58%–75% of the respondents reported not knowing whether SHA contained only water vapor as e-cigarette companies marketed 22. Social media may also be influencing people’s opinions about the relative risks of SHA. A recent review of e-cigarette related messages in social media found that e-cigarettes were perceived healthier and safer than traditional tobacco products on social media, and the smoke-free aspect of vaping was usually highlighted and promoted to be used where tobacco is restricted 23. Similarly, a recent study found adult vapers perceived advantages for their social environment (i.e., safety for bystanders) when switching from smoking to vaping, while youth vapers highlighted the trendiness of vaping as a perceived benefit 24. This misinformation may be influencing conclusions that users and nonusers of electronic products reach about the harms from both use and exposure to SHA from these products, particularly in their personal environment including their homes.

Based on the analysis of Tobacco Use Supplement to the Current Population Survey (TUS-CPS) over two decades, the overall prevalence of smoke-free home policies in the U.S. increased from 43.0% (1992–1993) to 83.0% (2010–2011) 25. Although increases were observed among both households without smokers (from 56.7% to 91.4%) and those with at least one smoker (from 9.6% to 46.1%) 25, a smoking ban at home is still much less likely reported by a current smoking respondent compared with a nonsmoker. The reported statistically significant adjusted odds ratio (aOR) of not having a complete home smoking ban among current smokers (compared to nonsmokers) ranged from 2.08 to 7.90 in the U.S. based on different populations 2632. Among smokers, home bans may be further influenced by factors such as time to first cigarette in the morning, number of cigarettes per day, and whether or not there are children in the household 26,3335. Home smoking bans not only reduce secondhand smoke risk for other household members, but the consistent adoption of a smoke-free home policy may also help reduce tobacco consumption among smokers 36. Further, youth smoking behaviors can be influenced by home smoking ban 37. Overall, the receptivity to a home smoking ban among young adults was associated with both their own and their parents’ smoking status 38. Previous studies showed that restrictions on smoking at home were associated with reduced smoking uptake and prevalence in teenagers 39,40. Interestingly, however, one study found that a complete home smoking ban was associated with an increase in odds of youth smoking onset when both parents were smokers, possibly due to inconsistent household message about smoking41.

Few studies have examined home policies regarding vaping, or compared vaping policy differences between smokers, vapers, and dual users. An internet-based panel survey conducted in 2017 on 4,107 US adults has found that respondents with high income, greater education, and children less than 18 years old at home were more likely to have vape-free home policies. Meanwhile, respondents living with e-cigarette or other tobacco product users were less likely to prohibit vaping inside the home 42. A recent examination of parent interviews conducted in 2017 in five pediatric practices found that parent dual users were more likely to have smoke-free than vape-free home policies, suggesting that some may perceive e-cigarette aerosol as safe for indoor use 43. Using recently released nationally representative Population Assessment of Tobacco and Health (PATH) Wave 3 data, we aim to examine the prevalence of smoking and vaping restrictions at homes among US adults and compare the differences in home vaping policies across smokers, vapers, and dual users. This is the largest study to date to compare home smoking and vaping rules across different categories of tobacco product use including never-users, ex-smokers, current vapers who never smoked, current vapers who were ex-smokers, current smokers, and dual users.

Methods

Study Population

The study was conducted using the nationally representative, cross-sectional PATH Wave 3 data collected from October 19, 2015 to October 23, 2016 on 28,148 adults (18 years and older) 44. The PATH study includes both tobacco and electronic nicotine product users and nonusers; the current analyses focus on adult cigarette smokers, e-cigarette users and non-tobacco users. The cross-sectional PATH Wave 3 data were de-identified open-source data that are publicly available from the National Addiction & HIV Data Archive Program (NAHDAP) website (https://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36498/datadocumentation).

Current Vaping and Smoking Status

Using multiple derived variables from the cross-sectional PATH Wave 3 data, we defined current smoking and vaping status based on current established cigarette smoking status, current established e-cigarette using status, and whether subjects had completely quit. We excluded all subjects who were currently established users of traditional cigars, cigarillos, filtered cigars, blunts only, pipes, hookah, snus pouches, smokeless tobacco, or dissolvable tobacco to have a clean vaping and cigarette smoking status. Currently established cigarette smokers were adult respondents who have smoked at least 100 cigarettes in their lifetime, and currently smoke every day or some days. Currently established e-cigarette users were adult respondents who had ever used an e-cigarette, had ever used fairly regularly, and currently used every day or some days. Current vaping and smoking status was defined according to the “yes” or “no” values of the three derived variables. The current vaping and smoking status included six categories: 1) dual users (“yes” values to both the current established cigarette smoker variable and the current established e-cigarette user variable), 2) current smokers (a “yes” value to current established cigarette smoker variable and a “no” value to current established e-cigarette user variable), 3) current vapers who were ex-smokers (a “no” value to current established cigarette smoker variable and a “yes” value to current established e-cigarette user variable and a “yes” value to have completely quit smoking cigarettes variable), 4) current vapers who never smoked (a “no” value to current established cigarette smoker variable and a “yes” value to current established e-cigarette user variable and an “inapplicable” or “have never smoked a cigarette in entire life, not even one or two puffs” value to have completely quit smoking cigarettes variable), 5) ex-smokers (“no” values to both the current established cigarette smoker variable and the current established e-cigarette user variable and a “yes” value to have completely quit smoking cigarettes variable), 6) never-users (“no” values to both the current established cigarette smoker variable and the current established e-cigarette user variable and an “inapplicable” or “have never smoked a cigarette in entire life, not even one or two puffs” value to have completely quit smoking cigarettes variable).

Outcome Variables and Covariates

Smoke-free and vape-free home policies were examined among the six categories of current vaping and smoking status. The smoke-free home policy variable was created from the statement that best describes rules about smoking a combustible tobacco product inside your home (PATH question: “Please think about everyone who might be in your home including children, adults, visitors, guests, or workers. For tobacco products that are burned, such as cigarettes, cigars, pipes or hookah, which statement best describes the rules about smoking a tobacco product inside your home?”) 45. The smoke-free home policy variable has two categories: 1) not allowed and 2) allowed. The “not allowed” category is the value of “It is not allowed anywhere or at any time inside my home” in the statement, while the “allowed” category combines the value of “It is allowed anywhere and at any time inside my home” and “It is allowed in some places or at some times inside my home” in the statement 45. Similarly, the vape-free home policy was created from the statement that best describes rules about using e-cigarettes and other electronic nicotine products inside your home (PATH question: “Now think about e-cigarettes and other electronic nicotine products. Which statement best describes the rules about using these products inside your home?”) 45. The vape-free home policy variable also has two categories: 1) not allowed (It is not allowed anywhere or at any time inside my home) and 2) allowed (either it is allowed anywhere and at any time inside my home or it is allowed in some places or at some times inside my home). Subjects who answered “Don’t know” or “Refused” to those two questions were excluded from the data analysis.

Covariates adjusted for in the data analysis included age categories, sex, marital status, race/ethnicity, education level, income level, insurance status, currently live with anyone who is a smoker, and currently live with anyone who is a vaper, frequency of smoking in lifetime, and frequency of vaping in lifetime.

Statistical Analysis

We used weighted frequency distributions and the Rao-Scott Modified Likelihood Ratio test to examine the association between covariates/outcomes and current vaping and smoking status. Multi-collinearity among covariates was examined using variance inflation factor (VIF) and no multi-collinearity was found among covariates. Listwise deletion was used to deal with missing values for the outcomes, predictor variables, and covariates. The associations of current vaping and smoking status with home vaping and smoking policies were examined by univariable and multivariable weighted logistic regression models. The first multivariable weighted logistic regression models included only the main effects. The moderation effects of important demographic variables were examined using the second multivariable weighted logistic regression models with both the main effects and interactions (current vaping and smoking status with important demographic variables). Linear contrasts were used to estimate the odds ratios of outcome variables for comparing different smoking and vaping status groups with never-users at each level of the moderators. The covariates were selected using purposeful model selection process 46. We adjusted the covariates in the multivariable weighted logistic regression models and used the balanced repeated replication (BRR) method to form replicate weights in variance estimation to account for the complex sampling design. Odds ratios and 95% confidence intervals were calculated to measure the associations of current vaping and smoking status with home vaping and smoking policies. Analyses were conducted using the proc survey procedures in SAS v9.4 (SAS Institute Inc., Cary, NC), with a .05 significance level for two-sided tests.

Results

Prevalence of allowing smoking and vaping inside home

The weighted prevalence of allowing smoking and vaping inside homes from the PATH Wave 3 data were 16.22% (95% CI: 15.48% – 17.00%) and 20.59% (95% CI: 19.76% – 21.45%) respectively. The PATH wave 3 data set included 606 dual users (1.42%, 95% CI: 1.28% – 1.59%), 412 current vapers who were ex-smokers (0.99%, 95% CI: 0.87% – 1.13%), 104 vapers who never smoked before and currently use e-cigarette exclusively (0.18%, 95% CI: 0.13% – 0.24%), 6,104 current smokers (14.56%, 95% CI: 14.03% – 15.11%), 6,315 ex-smokers (34.79%, 95% CI: 33.75% – 35.85%), and 8,728 never-users (47.84%, 95% CI: 46.55% – 49.13%). Table 1 shows the weighted prevalence of allowing smoking and vaping inside homes across current vaping and smoking status categories. Rates of allowing combustible tobacco product use inside the home varied across the main categories of tobacco product users including never-users, ex-smokers, current vapers who never smoked and now use e-cigarette exclusively, current vapers who were ex-smokers, dual users, and current smokers. Similarly, rates of allowing e-cigarette use inside the home also varied across the main categories of tobacco product users.

Table 1:

Characteristics of PATH Wave 3 adult participants across current vaping and smoking status.

Current vaping and smoking status (% with 95%CI)
Dual users Current smokers Current vapers who were ex-smokers Current vapers who never smoked and now use e-cigarettes exclusively Ex-smokers Never users P-value
Variables (n=606) (n=6104) (n=412) (n=104) (n=6335) (n=8728)
Home rule on combustible tobacco product use <.0001
 It is not allowed anywhere or at any time inside my home 62.16 (60.33, 64.03) 55.53 (54.98, 56.09) 83.59 (82.55, 84.64) 83.56 (81.18, 85.97) 91.41 (91.20, 91.63) 91.64 (91.20, 92.08)
 It is allowed anywhere or in some places, or at any time or some times inside my home 37.84 (35.31, 40.56) 44.47 (43.39, 45.57) 16.41 (13.52, 19.92) 16.44 (10.58, 25.49) 8.59 (8.00, 9.23) 8.36 (7.85, 8.89)
Home rule on e-cigarettes and other electronic nicotine products use <.0001
 It is not allowed anywhere or at any time inside my home 25.33 (22.72, 28.25) 54.23 (53.70, 54.78) 21.23 (18.19, 24.77) 55.68 (50.15, 61.79) 86.42 (86.24, 86.60) 89.57 (89.18, 89.96)
 It is allowed anywhere or in some places, or at any time or some times inside my home 74.67 (73.38, 75.98) 45.77 (44.69, 46.86) 78.77 (77.46, 80.10) 44.32 (38.01, 51.70) 13.58 (12.68, 14.54) 10.43 (9.92, 10.97)
Age (years) <.0001
 18–34 37.69 (35.16, 40.40) 28.05 (27.34, 28.79) 37.73 (34.73, 40.98) 81.68 (79.02, 84.41) 18.16 (17.57, 18.76) 33.23 (32.79, 33.69)
 35–64 56.36 (54.33, 58.47) 61.16 (60.55, 61.77) 51.95 (49.36, 54.67) 17.32 (10.08, 29.71) 52.16 (51.67, 52.67) 48.30 (47.89, 48.73)
 65+ 5.95 (3.94, 8.99) 10.79 (10.05, 11.59) 10.34 (7.63, 14.00) 1.06 (0.15, 8.51) 29.68 (28.57, 30.82) 18.47 (17.53, 19.45)
Sex <.0001
 Male 48.13 (45.84, 50.53) 49.52 (49.07, 49.99) 53.17 (50.63, 55.84) 58.79 (53.60, 64.53) 49.61 (49.16, 50.08) 40.29 (39.73, 40.87)
 Female 51.87 (49.69, 54.15) 50.48 (49.93, 51.03) 46.83 (44.07, 49.77) 41.21 (34.82, 48.84) 50.39 (49.98, 50.80) 59.71 (59.56, 59.88)
Marrital status <.0001
 Married 37.89 (35.36, 40.61) 38.37 (37.52, 39.23) 46.22 (43.42, 49.21) 12.66 (7.38, 21.64) 61.18 (60.54, 61.84) 55.82 (54.60, 57.06)
 Widowed, divorced or separated 28.18 (25.56, 31.08) 32.09 (31.42, 32.78) 22.52 (19.44, 26.07) 11.57 (6.04, 22.08) 23.00 (21.91, 24.14) 16.73 (15.50, 17.42)
 Never married 33.93 (31.34, 36.74) 29.54 (28.79, 30.32) 31.27 (28.16, 34.71) 75.77 (72.41, 79.29) 15.81 (15.36, 16.29) 27.74 (27.26, 28.25)
Ethnicity <.0001
 Hispanic 6.67 (4.87, 9.13) 12.37 (11.64, 13.14) 8.86 (6.51, 12.05) 27.05 (20.42, 35.77) 13.50 (12.96, 14.05) 18.05 (17.73, 18.39)
 Non-Hispanic 93.33 (92.97, 93.69) 87.63 (87.49, 87.77) 91.15 (90.57, 91.72) 72.95 (69.25, 76.90) 86.50 (86.25, 86.76) 81.95 (81.63, 82.28)
Race <.0001
 White alone 86.94 (86.24, 87.64) 78.18 (77.83, 78.52) 87.40 (86.59, 88.21) 70.46 (66.39, 74.74) 84.82 (84.54, 85.11) 73.10 (72.27, 73.94)
 Black alone 5.93 (4.21, 8.33) 14.51 (13.72, 15.36) 5.30 (3.42, 8.22) 11.27 (6.22, 20.35) 7.25 (6.73, 7.82) 14.57 (14.20, 14.97)
 Others 7.14 (5.28, 9.64) 7.31 (6.68, 8.00) 7.30 (5.12, 10.42) 18.32 (12.22, 27.46) 7.92 (7.17, 8.75) 12.32 (11.83, 12.84)
Education <.0001
 Less than high school 10.47 (8.32, 13.19) 17.73 (16.95, 18.55) 10.25 (7.77, 13.54) 13.49 (8.08, 22.50) 8.52 (7.93, 9.16) 10.11 (9.66, 10.59)
 GED 10.71 (8.54, 13.44) 10.81 (10.12, 11.55) 5.04 (3.22, 7.89) 0.83 (0.08, 8.23) 4.34 (3.76, 4.99) 3.26 (2.81, 3.78)
 High school graduate 23.17 (20.57, 26.11) 27.65 (26.93, 28.40) 26.56 (23.47, 30.06) 36.13 (29.53, 44.19) 20.42 (19.50, 21.39) 22.89 (22.13, 23.68)
 Some college (no degree) or associates degree 41.20 (38.73, 43.84) 31.90 (31.19, 32.63) 44.36 (41.52, 47.40) 34.35 (27.72, 42.56) 31.22 (30.68, 31.77) 30.57 (29.97, 31.19)
 Bachelor’s degree 11.53 (9.31, 14.30) 9.42 (8.75, 10.15) 9.09 (6.71, 12.30) 9.99 (5.29, 18.92) 22.30 (21.52, 23.10) 20.15 (19.37, 20.96)
 Advanced degree 2.91 (1.71, 4.93) 2.49 (2.08, 2.98) 4.70 (2.94, 7.50) 5.11 (1.74, 14.92) 13.21 (12.68, 13.76) 13.02 (12.55, 13.51)
Income <.0001
 Less than $10 000 14.71 (12.29, 17.63) 19.96 (19.18, 20.78) 8.81 (6.42, 12.09) 24.88 (18.22, 34.01) 6.69 (6.07, 7.37) 10.31 (9.64, 11.03)
 $10 000 to $24 999 23.63 (20.98, 26.61) 27.33 (26.33, 28.37) 18.54 (15.52, 22.15) 25.26 (18.60, 34.33) 15.88 (15.16, 16.65) 18.15 (17.44, 18.89)
 $25 000 to $49 999 28.00 (25.33, 30.95) 24.64 (23.85, 25.47) 27.90 (24.73, 31.47) 22.90 (16.34, 32.10) 22.32 (21.38, 23.31) 22.27 (21.52, 23.04)
 $50 000 to $99 999 23.33 (20.68, 26.31) 20.15 (19.40, 20.92) 28.87 (25.71, 32.43) 16.60 (10.62, 25.96) 30.89 (30.08, 31.72) 27.32 (26.18, 28.52)
 $100 000 or more 10.33 (8.12, 13.13) 7.92 (7.22, 8.69) 15.88 (12.90, 19.55) 10.36 (5.50, 19.62) 24.22 (23.27, 25.21) 21.96 (20.83, 23.15)
Health insurance <.0001
 Some private insurance 56.09 (54.04, 58.22) 49.69 (49.19, 50.19) 64.87 (62.62, 67.21) 64.25 (59.51, 69.36) 75.02 (74.47, 75.57) 72.61 (71.80, 73.42)
 No private insurance, some Medicare or Medicaid 24.46 (21.84, 27.39) 27.52 (26.50, 28.58) 19.89 (16.89, 23.43) 12.50 (7.19, 21.61) 15.63 (14.68, 16.63) 15.11 (14.45, 15.81)
 Other insurance only 4.68 (3.14, 6.95) 3.18 (2.73, 3.71) 1.91 (0.86, 4.22) 4.47 (1.55, 12.92) 2.59 (2.22, 3.03) 2.75 (2.36, 3.21)
 No insurance 14.77 (12.37, 17.62) 19.61 (18.74, 20.52) 13.33 (10.60, 16.75) 18.78 (12.67, 27.95) 6.76 (6.20, 7.38) 9.52 (8.95, 10.14)
Currently lived with anyone who is a smoker <.0001
 Yes 42.62 (40.18, 45.20) 43.35 (42.43, 44.29) 21.41 (18.37, 24.94) 20.91 (14.64, 29.87) 11.87 (11.16, 12.63) 11.03 (10.44, 11.66)
 No 57.38 (55.38, 59.45) 56.65 (56.25, 57.06) 78.60 (77.28, 79.94) 79.09 (76.08, 82.15) 88.13 (87.75, 88.51) 88.97 (88.66, 98.28)
Currently lived with anyone who is a vaper <.0001
 Yes 27.73 (25.11, 30.62) 4.26 (3.68, 4.94) 32.86 (29.78, 36.25) 22.46 (16.08, 31.38) 3.54 (3.09, 4.06) 2.91 (2.47, 3.42)
 No 72.28 (70.87, 73.70) 95.74 (95.71, 95.77) 67.15 (65.21, 69.12) 77.54 (74. 34, 80.81) 96.46 (96.36, 96.55) 97.09 (97.01, 97.18)
Number of cigarettes smoked in your entire life <.0001
 1 or more puffs but never a whole cigarette 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 2.63 (1.50, 4.61) 5.22 (2.68, 10.19) 10.07 (9.37, 10.82) 0.36 (0.27, 0.47)
 1 to 10 cigarettes (about 1/2 pack total) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 2.66 (1.52, 4.65) 5.26 (2.72, 10.24) 10.93 (10.25, 11.67) 0.74 (0.62, 0.88)
 11 to 20 cigarettes (about 1/2 pack to 1 pack) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 1.57 (0.74, 3.33) 9.16 (5.78, 14.54) 6.51 (5.98, 7.10) 0.53 (0.42, 0.68)
 21 to 50 cigarettes (more than 1 pack but less than 3 packs) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 3.04 (1.82, 5.10) 14.02 (10.02, 19.62) 5.46 (4.86, 6.14) 0.53 (0.43, 0.66)
 51 to 99 (more than 2 1/2 packs but less than 5 packs) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 1.55 (0.73, 3.29) 17.55 (10.52, 29.29) 2.74 (2.28, 3.28) 0.43 (0.34, 0.55)
 100 or more cigarettes (5 packs or more) 100.00 (100.00, 100.00) 100.00 (100.00, 100.00) 1.21 (0.51, 2.86) 0.00 (0.00, 0.00) 2.76 (2.35, 3.24) 0.00 (0.00, 0.00)
Number of times used [primary electronic nicotine product] in entire life <.0001
 1 time, even just a few puffs 1.70 (0.97, 3.00) 8.00 (7.47, 8.56) 1.07 (0.43, 2.68) 5.02 (2.50, 10.05) 3.55 (3.25, 3.88) 1.69 (1.50, 1.90)
 2 to 10 times 4.92 (3.64, 6.66) 16.13 (15.54, 16.74) 2.56 (1.45, 4.54) 13.49 (9.49, 19.18) 4.76 (4.44, 5.10) 1.61 (1.44, 1.80)
 11 to 20 times 5.51 (4.16, 7.30) 8.45 (7.92, 9.02) 2.04 (1.07, 3.91) 8.84 (5.47, 14.29) 1.99 (1.78, 2.24) 0.67 (0.55, 0.82)
 21 to 50 times 14.35 (12.45, 16.54) 7.32 (6.81, 7.87) 6.69 (4.88, 9.17) 22.05 (17.53, 27.77) 1.60 (1.41, 1.83) 0.42 (0.33, 0.54)
 51 to 99 times 12.51 (10.68, 14.66) 3.29 (2.88, 3.76) 6.59 (4.79, 9.07) 8.81 (5.43, 14.24) 0.62 (0.49, 0.78) 0.10 (0.06, 0.17)
 100 or more times 39.05 (37.06, 41.14) 3.83 (3.42, 4.30) 41.44 (39.01, 44.02) 33.66 (26.98, 42.01) 0.82 (0.67, 1.00) 0.11 (0.07, 0.19)

Comparison of home smoking and vaping policies among different smokers/vapers groups

Adjusted odds ratios of allowing combustible tobacco product use or allowing e-cigarette use inside the home, using never-users as the reference group, were calculated. Compared to never-users, current vapers who were ex-smokers were more likely to allow combustible tobacco product use (aOR = 1.62, 95% CI: 1.19 – 2.22) and much more likely to allow e-cigarette use inside their homes (aOR = 11.06, 95% CI: 8.04 – 15.21). Current vapers who never smoked and now use e-cigarettes exclusively were also more likely to allow combustible tobacco product use (aOR = 1.89, 95% CI: 1.14 – 3.14) and e-cigarette use inside their homes than never-users (aOR = 2.45, 95% CI: 1.53 – 3.93).

Similar to current vapers who were ex-smokers, dual users were more likely to allow combustible tobacco product use (aOR = 3.58, 95% CI: 2.88 – 4.45) and e-cigarette use inside their homes (aOR = 6.44, 95% CI: 5.01 – 8.28) compared to never-users. Current smokers were also more likely to allow combustible tobacco product use (aOR = 4.27, 95% CI: 3.73 – 4.89) and e-cigarette use inside their homes (aOR = 3.53, 95% CI: 3.06 – 4.06) than never-users. The policies of ex-smokers for combustible tobacco product use inside their homes were not significantly different from never-users (aOR = 1.05, 95% CI: 0.88 – 1.25), although they were slightly more likely to allow e-cigarette use inside their homes than never-users (aOR = 1.35, 95% CI: 1.15 – 1.58).

Characteristics of PATH Wave 3 adult respondents across current vaping and smoking status categories

Table 1 also shows the characteristics of PATH Wave 3 adult respondents across current vaping and smoking status categories. We note that current vapers who never smoked and now use e-cigarettes exclusively were mainly young adults (81.68% from age 18–34), with a majority of them never married (75.77%); conversely, ex-smokers who did not vape or smoke were mainly middle-aged adults or seniors. Males were more likely to vape than females. Never-users and ex-smokers were more likely to be married than vapers, smokers and dual users. Dual users and current smokers were more likely to live with another smoker than current vapers, while current vapers were more likely to live with someone who currently vapes than currently smokes.

Moderation effects of age, sex, marital status, and living with smokers or vapers

Table 2 and 3 showed the moderation effects of age, sex, marital status, and living with smokers or vapers on the association of smoking and vaping status with the probability of allowing combustible tobacco product use or vaping inside home. The age categories of respondents included three levels: < 35, 35–64, and ≥65, which were used to denote young adults, middle-aged adults, and older adults. When comparing vapers who were ex-smokers to never users, respondents who were young adults or older adults or not living with smokers or not living with vapers (regardless of their sex and marital status) were more likely to allow vaping inside home than smoking. Dual users who were less than 65 years old or female or married or not living with smokers or vapers were more likely to allow both smoking and vaping inside the home when compared to their ex-smokers and never-users counterparts. Regardless of sex, those who were living with a smoker, young and married dual users were more likely to allow vaping inside home than their current smoker, ex-smoker, and never user counterparts.

Table 2:

Adjusted odds ratios and their 95% confidence intervals of allowing combustible tobacco product use inside the home for the moderation effects of age, sex, marital status, whether living with smokers and whether living with vapers.

Moderators Dual users vs. never users Current smokers vs. never users Current vapers who were ex-smokers vs. never users Current vapers who never smoked and now use e-cigarettes exclusively vs. never users Ex-smokers vs. never uses
Age
18–34 5.97 (3.27, 10.88) 4.29 (3.04, 6.05) 2.05 (0.96, 4.40) 2.69 (0.34, 20.99) 1.30 (0.81, 2.09)
35–64 9.91 (5.97, 16.45) 8.93 (2.52, 31.60) 11.81 (2.32, 60.04) 2.53 (0.31, 20.43) 0.92 (0.15, 5.60)
65+ 0.00 (0.00, 0.00) 3.81 (2.39, 6.08) 3.77 (1.69, 8.39) 7.27 (0.96, 54.88) 1.43 (0.83, 2.47)
Sex
Male 3.95 (2.08, 7.51) 3.23 (2.35, 4.46) 1.64 (0.83, 3.24) 4.83 (0.76, 30.56) 1.52 (0.99, 2.32)
Female 5.97 (3.27, 10.88) 4.29 (3.04, 6.05) 2.05 (0.96, 4.40) 2.69 (0.34, 20.99) 1.30 (0.81, 2.09)
Marital Status
Married 5.97 (3.27, 10.88) 4.29 (3.04, 6.05) 2.05 (0.96, 4.40) 2.69 (0.34, 20.99) 1.30 (0.81, 2.09)
Widowed, divorced or separated 3.21 (1.52, 6.77) 5.06 (2.52, 10.15) 1.15 (0.46, 2.86) 1.64 (0.17, 15.60) 2.23 (0.13, 37.04)
Never married 1.64 (0.21, 12.56) 3.05 (1.74, 5.33) 2.24 (1.03, 4.90) 2.18 (0.29, 16.42) 1.20 (0.87, 1.65)
Currently lived with anyone who is a smoker
Yes 3.37 (1.75, 6.49) 2.10 (1.45, 3.05) 1.52 (0.59, 3.94) 5.02 (0.64, 39.13) 1.06 (0.63, 1.79)
No 5.97 (3.27, 10.88) 4.29 (3.04, 6.05) 2.05 (0.96, 4.40) 2.69 (0.34, 20.99) 1.30 (0.81, 2.09)
Currently lived with anyone who is a vaper
Yes 4.02 (1.76, 9.17) 3.78 (1.98, 7.21) 1.45 (0.57, 3.73) 1.32 (0.12, 14.98) 1.03 (0.45, 2.36)
No 5.97 (3.27, 10.88) 4.29 (3.04, 6.05) 2.05 (0.96, 4.40) 2.69 (0.34, 20.99) 1.30 (0.81, 2.09)

Note: The aORs in the model are estimated from the linear contrasts within the weighted logistic regression models include the effects of smoking and vaping status, age, sex, race, ethnicity, education level, household income, health insurance, marital status, living with smokers, living with vapers, frequency of smoking in lifetime, frequency of vaping in lifetime, interaction between smoking and vaping status and age, interaction between smoking and vaping status and sex, interaction between smoking and vaping status and martial status, interaction between smoking and vaping status and living with smokers, interaction between smoking and vaping status and living with vapers.

Table 3:

Adjusted odds ratios and their 95% confidence intervals of allowing e-cigarettes and other electronic nicotine products use inside the home for the moderation effects of age, sex, marital status, whether living with smokers and whether living with vapers.

Moderators Dual users vs. never users Current smokers vs. never users Current vapers who were ex-smokers vs. never users Current vapers who never smoked and now use e-Cigarettes exclusively vs. never users Ex-smokers vs. never uses
Age
18–34 17.69 (8.08, 38.70) 3.15 (2.19, 4.54) 19.20 (7.06, 52.26) 14.50 (3.63, 57.90) 2.08 (1.36, 3.17)
35–64 21.71 (12.19, 38.68) 15.60 (2.92, 83.40) 159.20 (19.65, 1289.40) 23.06 (4.88, 109.00) 0.72 (0.07, 7.12)
65+ 0.00 (0.00, 0.00) 2.77 (1.83, 4.19) 35.51 (12.80, 98.48) 34.96 (8.30, 147.30) 1.83 (1.15, 2.93)
Sex
Male 8.30 (4.57, 15.07) 2.43 (1.75, 3.37) 13.47 (6.40, 28.39) 12.06 (2.64, 55.05) 1.99 (1.44, 2.76)
Female 17.69 (8.08, 38.70) 3.15 (2.19, 4.54) 19.20 (7.06, 52.26) 14.50 (3.63, 57.90) 2.08 (1.36, 3.17)
Marital Status
Married 17.69 (8.08, 38.70) 3.15 (2.19, 4.54) 19.20 (7.06, 52.26) 14.50 (3.63, 57.90) 2.08 (1.36, 3.17)
Widowed, divorced or separated 9.81 (3.67, 26.21) 1.87 (0.88, 3.98) 11.12 (3.85, 32.14) 5.20 (0.77, 35.14) 13.40 (0.92, 194.60)
Never married 2.28 (0.46, 11.30) 2.04 (1.22, 3.41) 20.97 (7.92, 55.49) 13.08 (3.38, 50.65) 1.73 (1.29, 2.34)
Currently lived with anyone who is a smoker
Yes 9.64 (3.84, 24.23) 2.01 (1.26, 3.19) 9.99 (2.31, 43.11) 13.73 (2.61, 72.24) 1.50 (0.82, 2.73)
No 17.69 (8.08, 38.70) 3.15 (2.19, 4.54) 19.20 (7.06, 52.26) 14.50 (3.63, 57.90) 2.08 (1.36, 3.17)
Currently lived with anyone who is a vaper
Yes 3.60 (1.46, 8.86) 1.63 (0.84, 3.16) 5.74 (2.55, 12.97) 4.43 (0.60, 32.75) 1.36 (0.63, 2.90)
No 17.69 (8.08, 38.70) 3.15 (2.19, 4.54) 19.20 (7.06, 52.26) 14.50 (3.63, 57.90) 2.08 (1.36, 3.17)

Note: The aORs in the model are estimated from the linear contrasts within the weighted logistic regression models include the effects of smoking and vaping status, age, sex, race, ethnicity, education level, household income, health insurance, marital status, living with smokers, living with vapers, frequency of smoking in lifetime, frequency of vaping in lifetime, interaction between smoking and vaping status and age, interaction between smoking and vaping status and sex, interaction between smoking and vaping status and martial status, interaction between smoking and vaping status and living with smokers, interaction between smoking and vaping status and living with vapers.

Discussion

Principal findings

Using the nationally representative PATH Wave 3 cross-sectional data, the present study found that all vaping groups (including dual users) were more likely to allow vaping than smoking inside the home. This discrepancy is greatest among vapers who are ex-smokers, as observed from both the significantly different weighted prevalence and adjusted odds ratios. Vapers who are ex-smokers are also much less likely to have vape-free home policies relative to smokers, for whom the rates of smoke-free vs. vape-free home policies does not differ. Vapers who are ex-smokers are more likely to have smoke-free home policies relative to smokers and dual users.

These discrepancies between home smoking and vaping policies among vapers and between vapers and smokers suggest that vapers are switching to e-cigarettes or using e-cigarettes because they perceive that they are harm reducing, which they may be interpreting as “safe” and thus exposing others to e-cigarette aerosol in the home where they do not allow smoking. A similar pattern was observed for dual users, who were also more likely to have a rule prohibiting smoking inside the home than they were to have a rule not allowing vaping inside the home from both significantly different weighted prevalence and adjusted odds ratios.

Our moderation effects of age indicated that young vapers who were either dual users or ex-smokers were more likely to allow vaping inside homes than young smokers or ex-smokers. Previous research showed the higher prevalence of vaping in young adults relative to middle-aged and older adults 47. The majority of young vapers were either dual users or ex-smokers 47,48. They might have used e-cigarettes as an alternative way to quit smoking and perceive vaping is less harmful than smoking, thus were more likely to allow vaping inside the home than are current smokers and ex-smokers counterparts. Our moderation effects analysis further indicated that dual users who were young, female, and married were more likely to allow vaping inside their home than both their current smoker and ex-smoker counterparts. Again, this suggests e-cigarette are being perceived as safe enough to be used inside the home by many of the same individuals who do not allow cigarettes to be smoked in the home. This finding is consistent with a recent study that suggests parents who were dual users may perceive e-cigarette use in the home as safe for their children 43.

Public health implications for restricting vaping inside home

In light of the emerging literature on potential health effects of secondhand e-cigarette aerosol exposure, findings from this study raises concerns. Although the World Health Organization (WHO) recommends not using e-cigarettes and other electronic nicotine products inside home to minimize the risk to bystanders exposed to the aerosols, the large majority of current vapers and dual users still vape inside homes 49. Since the 1970s, protecting innocent bystanders from secondhand smoke has been the central issue in tobacco control policy in the United States 50,51. Committing to create healthy environments for nonsmokers, US public health community had advocated the smoke-free policy in public areas such as bars, restaurants, workspaces, schools etc. With the increasing prevalence of e-cigarettes in recent years, the US public health community (nearly 40 US public health organizations) has recommended that the Department of Housing and Urban Development ban both smoking and vaping in public housing because of evidence of potential risks that vaping poses to nonsmokers. The 2016 US Surgeon General report also emphasized the importance of protecting bystanders from secondhand smoke and e-cigarette aerosols 52. There is a need for enhanced public communication from trusted sources about SHA that can help people form more accurate opinions about e-cigarettes based on the emerging scientific evidence. This study also supports the increased need for interventions involving current vapers and dual users to prevent exposure of household members to potentially toxic e-cigarette aerosol. Interventions delivered through healthcare providers 43 and public awareness campaigns 53 should prioritize the prevention of secondhand and thirdhand e-cigarette aerosol exposure as important goals. The latter could be tested by adapting existing channels, such as the Food and Drug Administration’s (FDA’s) “The Real Cost” peer-to-peer campaign, the FDA’s “Every Try Counts“ campaign and the FDA’s “Fresh Empire” public education campaign, to include secondhand e-cigarette aerosol and vape-free home messaging to examine the effects of perception and home policies to protect non-users from exposure in the home.

The present study found that, though ex-smokers who did not vape were very similar to never-users in terms of their smoke-free and vape-free rules, ex-smokers who vaped and dual users were much less likely to have vape-free rules. This finding suggests that smokers who try to quit smoking by transitioning to e-cigarettes may continue to create an unsafe home environment through both dual-use and e-cigarette exclusive pathways. The broader implications of this finding are that, for overall public health, complete cessation should be the primary goal to result in the least amount of exposures among household members. In this context, a non-aerosolized form of nicotine, through increasing access to FDA approved nicotine replacement products, may be the most recommended form of cessation assistance for those who are not yet ready to stop nicotine use. Altogether, education, intervention and cessation efforts are all needed to restrict smoking and vaping inside homes to create a safe environment for all household members and bystanders.

Strength and limitations

The nationally representative PATH survey data with a large sample size increased the robustness of the current study’s estimated proportions of smoke-free and vape-free home policies among different vaping and smoking status groups. The self-reported cross-sectional data are subject to recall bias, which is a limitation of the current study. In addition, the current study may have failed to account for other confounding variables such as the knowledge of third-hand smoke, the age of children inside their home, and whether participants lived in apartments with building/property smoking bans (e.g., in MUH common areas, patios, individual units), which were not included in the publicly available PATH Wave 3 dataset. Further, the PATH Wave 3 dataset does not include the question on vaping and smoking restrictions in the car and perceived health risks of electronic vs traditional cigarettes, which will be included in future PATH data and will be evaluated in future studies. In addition, the PATH Wave 3 data were collected four years ago, thus the application to current situation could be limited due to the evolution of vaping technology and the increased media coverage around the potential harms of e-cigarettes. For example, the recent national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) in US that led to 2558 nonfatal cases and 60 fatal cases as of January 7, 2020 may have influenced more people to adopt home vaping policies 54. In addition, the recent US Food and Drug Administration (FDA) flavor enforcement policy that restricted the sale of all flavored, cartridge-based e-cigarettes, other than tobacco or menthol flavors may affect who adopts home vaping policies 55.

Conclusions

Although the long-term health effects of exposure to e-cigarette aerosol remain unknown, research has demonstrated the presence of both secondhand and thirdhand e-cigarette vapor that includes constituents with potential short-term harm to human health. Current vapers and dual users might use e-cigarettes for presumed harm reduction, but may not be aware of potential secondhand and thirdhand risks to other household members. The large percentage of vapers (dual users, and vapers who both are and are not ex-smokers) who allow e-cigarettes use inside the home indicates a necessity for increased education and interventions as well as cessation efforts to promote completely smoke-free and vape-free homes to protect the health of all household members. Because of the implications of household exposure to e-cigarette aerosol, clinicians should consider treating e-cigarette users with non-aerosolized, FDA-approved tobacco cessation medications for those unwilling or unable to quit nicotine. Given the limited success rates of even the best cessation interventions and issues of access/cost, implementing effective indoor smoking and vaping bans is a highly obtainable prevention strategy that yields immediate benefits by eliminating the primary source of indoor secondhand and thirdhand smoke pollution. In addition to health concerns related to the e-cigarette user, the current study provides a separate rationale for caution in the promotion of e-cigarettes for harm reduction relative to the risk exposures to others in the home.

Highlights.

  • All vaping groups were more likely to allow vaping than smoking inside the home.

  • Vapers (ex-smokers and dual users) were more likely than smokers to allow vaping in their homes.

  • Vapers who switch to e-cigarettes may be interpreting “harm reduction” as “safe”.

  • Harm reduction promotion of e-cigarettes needs to consider risk exposures to others.

  • Young and married dual users who live with smokers allow home vaping at higher rates than smoker and ex-smoker counterparts.

Acknowledgements

Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) Center for Tobacco Products under Award Number U54CA228110 (DL, ZX, IR, SM, MBT, DJO). This research was also supported by the University of Rochester CTSA award number UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health (DL). In addition, this research was supported by the University of Rochester Infection and Immunity: From Molecules to Populations (IIMP) award number BWF-1014095 from the Burroughs Welcome Fund of Institutional Program Unifying Population and Laboratory Based Sciences (HS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflicting interests: Authors have no potential conflict of interest to declare.

Data Availability: The PATH Wave 3 data can be publicly accessed from the National Addiction & HIV Data Archive Program (NAHDAP) website public user files (https://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36498/datadocumentation).

References

  • 1.Kaur G, Bagam P, Pinkston R, Singh DP, Batra S. Cigarette smoke-induced inflammation: NLRP10-mediated mechanisms. Toxicology. 2018;398–399:52–67. [DOI] [PubMed] [Google Scholar]
  • 2.Arechavala T, Continente X, Perez-Rios M, Schiaffino A, Fernandez E, Lopez MJ. Sociodemographic factors associated with secondhand smoke exposure and smoking rules in homes with children. Eur J Public Health. 2019. [DOI] [PubMed]
  • 3.Kaplan B, Carkoglu A, Ergor G, et al. Evaluation of Secondhand Smoke Using PM2.5 and Observations in a Random Stratified Sample in Hospitality Venues from 12 Cities. Int J Environ Res Public Health. 2019;16(8). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bals R, Boyd J, Esposito S, et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J. 2019;53(2). [DOI] [PubMed] [Google Scholar]
  • 5.Morris PB, Ference BA, Jahangir E, et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol. 2015;66(12):1378–1391. [DOI] [PubMed] [Google Scholar]
  • 6.Avino P, Scungio M, Stabile L, Cortellessa G, Buonanno G, Manigrasso M. Second-hand aerosol from tobacco and electronic cigarettes: Evaluation of the smoker emission rates and doses and lung cancer risk of passive smokers and vapers. Sci Total Environ. 2018;642:137–147. [DOI] [PubMed] [Google Scholar]
  • 7.Hess IM, Lachireddy K, Capon A. A systematic review of the health risks from passive exposure to electronic cigarette vapour. Public Health Res Pract. 2016;26(2). [DOI] [PubMed] [Google Scholar]
  • 8.Bayly JE, Bernat D, Porter L, Choi K. Secondhand Exposure to Aerosols From Electronic Nicotine Delivery Systems and Asthma Exacerbations Among Youth With Asthma. Chest. 2019;155(1):88–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Alzahrani T, Pena I, Temesgen N, Glantz SA. Association Between Electronic Cigarette Use and Myocardial Infarction. American Journal of Preventive Medicine. 2018;55(4):455–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fuoco FC, Buonanno G, Stabile L, Vigo P. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environmental Pollution. 2014;184:523–529. [DOI] [PubMed] [Google Scholar]
  • 11.Bhatta DN, Glantz SA. Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health. J Am Heart Assoc. 2019;8(12):e012317. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 12.Fuoco FC, Buonanno G, Stabile L, Vigo P. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ Pollut. 2014;184:523–529. [DOI] [PubMed] [Google Scholar]
  • 13.Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med. 2001;58(10):649–655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Choi H, Schmidbauer N, Spengler J, Bornehag CG. Sources of propylene glycol and glycol ethers in air at home. Int J Environ Res Public Health. 2010;7(12):4213–4237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One. 2015;10(2):e0116732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Goniewicz ML, Lee L. Electronic cigarettes are a source of thirdhand exposure to nicotine. Nicotine Tob Res. 2015;17(2):256–258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Khachatoorian C, Jacob Iii P, Benowitz NL, Talbot P. Electronic cigarette chemicals transfer from a vape shop to a nearby business in a multiple-tenant retail building. Tob Control. 2018. [DOI] [PMC free article] [PubMed]
  • 18.Son Y, Giovenco DP, Delnevo C, Khlystov A, Samburova V, Meng Q. Indoor Air Quality and Passive E-cigarette Aerosol Exposures in Vape-shops. Nicotine Tob Res. 2020. [DOI] [PMC free article] [PubMed]
  • 19.Mello S, Bigman CA, Sanders-Jackson A, Tan AS. Perceived Harm of Secondhand Electronic Cigarette Vapors and Policy Support to Restrict Public Vaping: Results From a National Survey of US Adults. Nicotine Tob Res. 2016;18(5):686–693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bigman CA, Mello S, Sanders-Jackson A, Tan ASL. Assertive communication about others’ smoking and vaping in public venues: Results from a National Survey of US adults. Addict Behav. 2018;87:196–199. [DOI] [PubMed] [Google Scholar]
  • 21.Nguyen KH, Tong VT, Marynak K, King BA. Perceptions of Harm to Children Exposed to Secondhand Aerosol From Electronic Vapor Products, Styles Survey, 2015. Prev Chronic Dis. 2017;14:E41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tan ASL, Mello S, Sanders-Jackson A, Bigman CA. Knowledge about Chemicals in e-Cigarette Secondhand Vapor and Perceived Harms of Exposure among a National Sample of U.S. Adults. Risk Anal. 2017;37(6):1170–1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.MKMBLTJ J. The Messages Presented in Electronic Cigarette–Related Social Media Promotions and Discussion: Scoping Review. J Med Internet Res. 2019;21(2):e11953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Romijnders KAGJ, van Osch L, de Vries H, Talhout R. Perceptions and Reasons Regarding E-Cigarette Use among Users and Non-Users: A Narrative Literature Review. International Journal of Environmental Research and Public Health. 2018;15(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.King BA, Patel R, Babb SD, Hartman AM, Freeman A. National and state prevalence of smoke-free rules in homes with and without children and smokers: Two decades of progress. Prev Med. 2016;82:51–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Clark PI, Schooley MW, Pierce B, Schulman J, Hartman AM, Schmitt CL. Impact of home smoking rules on smoking patterns among adolescents and young adults. Prev Chronic Dis. 2006;3(2):A41. [PMC free article] [PubMed] [Google Scholar]
  • 27.Shelley D, Fahs MC, Yerneni R, Qu J, Burton D. Correlates of household smoking bans among Chinese Americans. Nicotine Tob Res. 2006;8(1):103–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gonzales M, Malcoe LH, Kegler MC, Espinoza J. Prevalence and predictors of home and automobile smoking bans and child environmental tobacco smoke exposure: a cross-sectional study of U.S.- and Mexico-born Hispanic women with young children. BMC Public Health. 2006;6:265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Berg CJ, Daley CM, Nazir N, et al. Smoke-Free Policies in the Workplace and in the Home among American Indians. J Health Dispar Res Pract. 2012;5(2):7. [PMC free article] [PubMed] [Google Scholar]
  • 30.Hughes SC, Corcos IA, Hofstetter CR, Hovell MF, Irvin VL. Longitudinal study of household smoking ban adoption among Korean Americans. Am J Prev Med. 2009;37(5):437–440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Schmidt LM, Reidmohr AA, Helgerson SD, Harwell TS. Secondhand Smoke Exposure and Smoke-Free Policy Support Among Public Housing Authority Residents in Rural and Tribal Settings. J Community Health. 2016;41(6):1116–1121. [DOI] [PubMed] [Google Scholar]
  • 32.Norman GJ, Ribisl KM, Howard-Pitney B, Howard KA. Smoking bans in the home and car: Do those who really need them have them? Prev Med. 1999;29(6 Pt 1):581–589. [DOI] [PubMed] [Google Scholar]
  • 33.Ossip DJ, Johnson T, Assibey-Mensah V, et al. Smoke-Free Home and Vehicle Policies Among Community College Smokers. Health Educ Behav. 2018;45(4):540–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Heck JE, Stucker I, Allwright S, et al. Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic. Eur Respir J. 2010;35(5):969–979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tyc VL, Puleo E, Emmons K, de Moor JS, Ford JS. Smoking Restrictions Among Households of Childhood and Young Adult Cancer Survivors: Implications for Tobacco Control Efforts. J Adolesc Young Adult Oncol. 2013;2(1):17–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Zhang X The association between indoor smoke-free home rules and the use of cigar and smokeless tobacco: A longitudinal study. Addict Behav. 2017;74:153–155. [DOI] [PubMed] [Google Scholar]
  • 37.Klein EG, Forster JL, Erickson DJ, Lytle LA, Schillo B. The relationship between local clean indoor air policies and smoking behaviours in Minnesota youth. Tob Control. 2009;18(2):132–137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Berg CJ, Lessard L, Parelkar PP, et al. College student reactions to smoking bans in public, on campus and at home. Health Educ Res. 2011;26(1):106–118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wakefield MA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, Ruel EE. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ. 2000;321(7257):333–337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Proescholdbell RJ, Chassin L, MacKinnon DP. Home smoking restrictions and adolescent smoking. Nicotine Tob Res. 2000;2(2):159–167. [DOI] [PubMed] [Google Scholar]
  • 41.O’Loughlin JL, Barry AD, O’Loughlin EK, Tremblay M, AdoQuest T. Home smoking bans may increase the risk of smoking onset in children when both parents smoke. Nicotine Tob Res. 2014;16(7):1009–1013. [DOI] [PubMed] [Google Scholar]
  • 42.Gentzke AS, Homa DM, Kenemer JB, Gomez Y, King BA. Rules to prohibit the use of electronic vapor products inside homes and personal vehicles among adults in the U.S., 2017. Prev Med. 2018;114:47–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Drehmer JE, Nabi-Burza E, Hipple Walters B, et al. Parental Smoking and E-cigarette Use in Homes and Cars. Pediatrics. 2019;143(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hyland A, Ambrose BK, Conway KP, et al. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study. Tobacco Control. 2016. [DOI] [PMC free article] [PubMed]
  • 45.United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files. Inter-university Consortium for Political and Social Research [distributor], 2019-11-21 10.3886/ICPSR36498.v10 [DOI]
  • 46.Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Cooper M, Harrell MB, Perry CL. Comparing young adults to older adults in e-cigarette perceptions and motivations for use: implications for health communication. Health Educ Res. 2016;31(4):429–438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Harrell PT, Brandon TH, England KJ, et al. Vaping Expectancies: A Qualitative Study among Young Adult Nonusers, Smokers, Vapers, and Dual Users. Subst Abus-Res Treat. 2019;13. [DOI] [PMC free article] [PubMed]
  • 49.(WHO) WHO. Electronic nicotine delivery systems. World Health Organization (WHO) 2014. [Google Scholar]
  • 50.Fairchild AL, Bayer R, Lee JS. The E-Cigarette Debate: What Counts as Evidence? Am J Public Health. 2019;109(7):1000–1006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Green SH, Bayer R, Fairchild AL. Evidence, Policy, and E-Cigarettes – Will England Reframe the Debate? New Engl J Med. 2016;374(14):1301–1303. [DOI] [PubMed] [Google Scholar]
  • 52.Murthy VH. E-Cigarette Use Among Youth and Young Adults A Major Public Health Concern. Jama Pediatrics. 2017;171(3):209–210. [DOI] [PubMed] [Google Scholar]
  • 53.U.S. Department of Health and Human Services (Accessed on 28 June 2020). Tobacco-Free Campaigns. Retrieved from https://betobaccofree.hhs.gov/tobacco-free-campaigns.
  • 54.Werner AK, Koumans EH, Chatham-Stephens K, et al. Hospitalizations and Deaths Associated with EVALI. N Engl J Med. 2020;382(17):1589–1598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products (April 2020). Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization (Revised). Retrieved from https://www.fda.gov/media/133880/download.

RESOURCES